Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?
Introduction The aim of the current study was to identify whether serum pentraxin 3 (PTX3) level could be a marker of increased inflammation in rheumatoid arthritis (RA) patients. Material and methods The study included 41 patients diagnosed with RA according to the American College of Rheumatology...
Enregistré dans:
Auteurs principaux: | Ozlem Balbaloglu, Seda Sabah Ozcan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b15ac59f1e4e43aaa4d95a9021dcac2a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
par: Han Q, et autres
Publié: (2021) -
Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections
par: Raffaella Parente, et autres
Publié: (2021) -
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study
par: Wang Y, et autres
Publié: (2021) -
Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
par: Zhao X, et autres
Publié: (2021) -
Non-Surgical Periodontal Therapy Could Improve the Periodontal Inflammatory Status in Patients with Periodontitis and Chronic Hepatitis C
par: Dorin Nicolae Gheorghe, et autres
Publié: (2021)